Sort
40,608 grants matching “prostate cancer”
ACCESS-PC: Advancing Care Coordination to Enhance Shared Care for Complex Survivors in Primary Care
$967,120Denalee M. O'Malley · Rutgers Biomedical And Health Sciences · U01 · FY2024 · CA
ACCESS-PC: Advancing Care Coordination to Enhance Shared Care for Complex Survivors in Primary Care
$967,120Denalee M. O'Malley · Rutgers Biomedical And Health Sciences · U01 · FY2025 · CA
Clinical Pharmacogenetics
$966,995William Douglas Figg · Division Of Basic Sciences - Nci · ZIA · FY2023 · CA
UPSTATE CAROLINA COMMUNITY CLINICAL ONCOLOGY PROGRAM
$966,615Spartanburg Regional Medical Center · U10 · FY2000 · CA
RTOG Biospecimen Repository
$965,989Walter John Curran · American College Of Radiology · U24 · FY2012 · CA
Modeling to Improve Prostate Cancer Outcomes Across Diverse Populations
$965,899Ruth D Etzioni · Fred Hutchinson Cancer Research Center · U01 · FY2019 · CA
ARKANSAS SPECIAL POPULATIONS ACCESS NETWORK (A-SPAN)
$965,549University Of Arkansas Med Scis Ltl Rock · U01 · FY2004 · CA
Development
$965,464Ana M Navarro · University Of California, San Diego · U54 · FY2012 · CA
TARGETING GLUTAMINASE ISOFORMS FOR THERAPY-RESISTANT PROSTATE CANCER
$964,851Duke University · · FY2019 · Defense Health Agency
Early Phase Clinical Cancer Prevention Consortium
$964,652Dean E. Brenner · University Of Michigan At Ann Arbor · UG1 · FY2020 · CA
PROSTATE, LUNG, COLORECTAL AND OVARIAN (PLCO) CANCER
$964,370University Of Alabama At Birmingham · N01 · FY2000 · CN
Comparative Biomedical Scientist Training Program
$963,134Robert Simpson · Division Of Basic Sciences - Nci · ZIG · FY2015 · CA
ACHIEVING BETTER CANCER DIAGNOSIS (ABCD): Identifying, supporting, and learning from marginalized patients who experience delayed cancer diagnosis
$962,876Gordon David Schiff · Brigham And Women'S Hospital · R18 · FY2023 · HS
MOLECULAR CLASSIFICATION OF PROSTATE CANCER
$962,585Sloan-Kettering Institute For Cancer Res · U01 · FY2001 · CA
LEVERAGING AGE AND COMORBIDITY TO OPTIMIZE TREATMENT SELECTION IN MEN WITH RECURRENT PROSTATE CANCER
$962,500Cedars-Sinai Medical Center · · FY2017 · Department of the Army
Human PSMA MAb Radioimmunotherapy for Prostate Cancer
$962,160Progenics Pharmaceuticals, Inc. · R44 · FY2005 · CA
Novel Targets for Vaccine Therapy
$962,130Claudia Palena · Division Of Basic Sciences - Nci · ZIC · FY2014 · CA
Development
$962,061Ana M Navarro · University Of California, San Diego · U54 · FY2011 · CA
TARGETING METABOLIC PATHWAYS IN OVERCOMING DRUG RESISTANCE IN METASTATIC CASTRATE-RESISTANT PROSTATE CANCER
$961,832Case Western Reserve University · · FY2018 · Department of the Army
Etiological Studies of Gastric Carcinoma
$961,747Pelayo Correa · Vanderbilt University · P01 · FY2013 · CA
Rapid Identification of Pathogenic Bacteria and Sepsis Diagnosis
$961,238Ray Anthony Martino · Isense, Llc · R44 · FY2014 · AI
Breast &prostate cancer &hormone-related gene variants
$960,687International Agency For Res On Cancer · U01 · FY2004 · CA
Developmental Funds
$960,595Michael A Caligiuri · Ohio State University · P30 · FY2009 · CA
Intratumor heterogeneity and tumor evolution
$960,545Karl Ried · Division Of Basic Sciences - Nci · ZIA · FY2020 · CA
Tissue Processing-Sequencing Facility
$960,311Cathy D Vocke · Division Of Basic Sciences - Nci · ZIC · FY2024 · CA